SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesequity

DocGo Inc. (DCGO) News

Follow DocGo Inc. (DCGO) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 14 public stories across 11 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol DCGO Asset equity Sector Markets 90 days 8 Last 0.1747 Updated Nov 10, 2026, 02:05 PM UTC Open live news feed Open DCGO chart & news
M DocGo Reports Q3 2026 Results, Begins CEO Transition DocGo projected 2026 revenue of approximately $300 million and reaffirmed adjusted EBITDA guidance for a loss of $17 million to $22 million. EQUITY | Nov 10, 2026, 02:05 PM UTC M DocGo Reports Q3 Revenue of $73.4 Million and 29.7% Gross Margin DocGo reported third-quarter 2026 revenue of $73.4 million, GAAP gross profit of $21.8 million and a net loss of $18.3 million. Adjusted EBITDA was a loss of $3.2 million; the company also lowered its 2026 revenue outloo EQUITY | Nov 09, 2026, 09:15 PM UTC M DocGo Reports Third-Quarter 2026 Results and CEO Transition DocGo announced results for the quarter ended September 30, 2026, and a CEO transition. EQUITY | Nov 09, 2026, 09:06 PM UTC M DocGo to Report Third-Quarter 2026 Results on November 9 DocGo plans to host a conference call and webcast at 5:00 p.m. ET on November 9, 2026. EQUITY | Nov 03, 2026, 12:36 PM UTC L DocGo Price Target Maintained With a $3.00/Share by Needham Ratings actions from Benzinga NEWS | Sep 30, 2026, 10:12 AM UTC L Needham reiterates Buy rating on DocGo, $3 price target Needham reiterated their Buy rating on DocGo's stock with a price target of $3.00.The price target implies an upside of 715.2% from the Sep 29 close of $0.37.Key takeaways from the analyst noteStrategic Acquisition Enhan MNA | Sep 30, 2026, 10:01 AM UTC L DocGo Announces Upcoming Webinar to Outline Vision and Details of the Pending Hicuity Health Acquisition DocGo Inc. (Nasdaq: DCGO) (“DocGo”), a leading provider of technology-enabled mobile health and medical transportation services, announced today that Lee Bienstock, Chief Executive Officer, and senior Hicuity Health exec MNA | Sep 23, 2026, 11:35 AM UTC L DocGo CEO Lee Bienstock to meet in 1x1 at Morgan Stanley healthcare conference DocGo said CEO Lee Bienstock will participate in 1x1 meetings at the Morgan Stanley 24th Annual Global Healthcare Conference on Wednesday. EQUITY | Sep 01, 2026, 11:35 AM UTC L DocGo shares fall after worse Q2 results, FY2026 sales guidance narrows DocGo reports worse-than-expected Q2 financial results and narrows its FY2026 sales guidance, prompting shares to trade lower, per Alpaca Benzinga Live. EARNINGS | Aug 18, 2026, 02:28 PM UTC L DocGo reports Q2 2026 results, signs Hicuity Health deal DocGo reported Q2 2026 revenue of $73.4 million, a year-over-year decline from $80.4 million, and said it signed a definitive agreement to acquire Hicuity Health. EARNINGS | Aug 17, 2026, 09:51 PM UTC L DocGo narrows FY2026 sales guidance to $305 million-$310 million DocGo (NASDAQ: DCGO) narrows its FY2026 sales outlook to $305.000 million-$310.000 million from $300.000 million-$315.000 million, versus a $306.281 million estimate. EARNINGS | Aug 17, 2026, 08:23 PM UTC L DocGo to report narrower Q2 loss after raising FY2026 sales guidance DocGo Inc. will release its second-quarter earnings after Monday’s close, with analysts expecting a 15-cent loss per share on $75.57 million of revenue versus a 21-cent loss and $80.42 million a year ago. EARNINGS | Aug 14, 2026, 10:57 AM UTC L Did DocGo Inc. Insiders Breach their Fiduciary Duties to Shareholders? Did DocGo Inc. Insiders Breach their Fiduciary Duties t EQUITY | Jul 03, 2026, 04:30 PM UTC L DocGo Extends Share Repurchase Program Expiration To December 31 Sec Filing REGULATION | Jul 02, 2026, 08:23 PM UTC